22157.jpg
Worldwide Precision Medicine Industry to 2025 - Targeted Gene Therapy Presents Opportunities
March 12, 2021 05:03 ET | Research and Markets
Dublin, March 12, 2021 (GLOBE NEWSWIRE) -- The "Global Precision Medicine Market (2020-2025) by Technology, Sequencing Technology, Products, Applications, End-Users, Route of Administration,...
22157.jpg
Outlook on the CAR-T Cell Therapy Global Market to 2027 - Capitalize on Emerging Trends
January 05, 2021 06:33 ET | Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials and Trends, 2021" report has been added to ResearchAndMarkets.com's offering. ...
Kinnate_LogoColor@10x.png
Kinnate Biopharma Announces Pricing of Initial Public Offering
December 02, 2020 22:02 ET | Kinnate Biopharma
SAN FRANCISCO and SAN DIEGO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a biopharmaceutical company focused on the discovery and development of small...
22157.jpg
Global Theranostics Markets Report 2020: Oncology Segment Market for Theranostics Should Grow from $73.1 Billion in 2020 to $119.7 Billion by 2025
October 26, 2020 07:23 ET | Research and Markets
Dublin, Oct. 26, 2020 (GLOBE NEWSWIRE) -- The "Theranostics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for theranostics should grow from $80.4...
AMR Logo.png
Uveitis Treatment Market to Reach $687.4 Mn, by 2026: AMR
June 22, 2020 10:26 ET | Allied Market Research
Portland, OR, June 22, 2020 (GLOBE NEWSWIRE) -- According to the report, the global uveitis treatment market was pegged at $500.7 million in 2019 and is expected to reach $687.4 million by 2026,...
Logo-BCC-Research.jpg
Global Cancer Stem Cell Market to Reach Nearly $2B by 2022
January 17, 2018 12:29 ET | BCC Research
WELLESLEY, Mass., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Cancer stem cells have been found in a range of human tumors and are potential targets for cancer treatment. The global cancer stem cell...
New Research Study Demonstrates Applicability of VisionGate’s 3-Dimensional Cell-CT™ Imaging and Analysis Platform
December 11, 2017 15:27 ET | VisionGate, Inc.
Seattle, WA, Dec. 11, 2017 (GLOBE NEWSWIRE) -- New research conducted by Arizona State University’s (ASU) Biodesign Institute and published in Science Advances (published by the American Association...
admera_health_final_logo_transparent_final.jpg
Admera Health Expands Oncology Test Portfolio with Launch of OncoGxSelect™ at the AMP 2016 Annual Meeting
November 09, 2016 09:13 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J. and CHARLOTTE, N.C., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Molecular diagnostics company, Admera Health announced the official launch of OncoGxSelect™ while exhibiting at the...
MolecularMD Corp. Obtains Exclusive License to LKB1 Uses in Non-Small Cell Lung Cancer
January 28, 2013 08:30 ET | MolecularMD
PORTLAND, OR--(Marketwire - Jan 28, 2013) - MolecularMD Corp. announced today that it has entered into a license agreement granting the company exclusive patent rights to cancer diagnosis...